COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
LEAD Therapeutics raises $17 million in Series A financing
News | 11. 05. 2007
LEAD Therapeutics
LEAD Therapeutics, Inc., a chemistry-driven drug discovery company, today announced it has raised $17 million in Series A financing co-led by Pappas Ventures and ProQuest Investments. Also participating in this financing round is Mustang Ventures, a China-focused venture firm.
